Results 211 to 220 of about 685,850 (392)

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

2: 45 p.m.: HDL-CHOLESTEROL AND APO A-I CONCENTRATION IN CONDITIONED MIDDLE-AGED MEN WITH LONG TERM ALTERATION IN FAT INTAKE AND WITH DETRAINING

, 1981
Bente Kiens, P. Gad, B. Vessby, Hans Lithell   +3 more
openalex   +1 more source

U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies

European Heart Journal, 2018
C. M. Madsen, A. Varbo, A. Tybjærg‐Hansen, R. Frikke-Schmidt, B. Nordestgaard   +4 more
semanticscholar   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

EFFECT OF STRICT DIABETIC CONTROL ON SERUM LIPID AND HDL-LCAT METABOLISM DURING HOSPITALIZATION

, 1989
Takashi Iizuka
openalex   +2 more sources

Longitudinal Cohort Study of Metabolomic Markers Associated With Type 2 Diabetes Risk in Korean Adults

Chronic Diseases and Translational Medicine, EarlyView.
Md. Kamruzzaman, Catherine Apio, Md. Mozaffar Hosain, Min Kyong Moon, Geum‐Sook Hwang, Eunyong Ahn, Taesung Park   +6 more
wiley   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

Relation between Running Distance and Plasma HDL-Cholesterol Level in Middle-Aged Runners

, 1988
Mitsuru Higuchi, Kensuke Iwaoka, Shuhei Kobayashi, Toshitaka TAMAI, Hirotada Takai, Tsuguhiko NAKAI   +5 more
openalex   +2 more sources

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Association between glycated hemoglobin/high-density lipoprotein ratio and nonalcoholic fatty liver disease in a U.S. nondiabetic population: a cross-sectional study based on NHANES 2017-2020 data. [PDF]

BMC Gastroenterol
Zheng X, Wang H.
europepmc   +1 more source